183 related articles for article (PubMed ID: 21561740)
21. Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression.
Hostiuc S; Rusu MC; Negoi I; Drima E
BMC Psychiatry; 2018 Jan; 18(1):2. PubMed ID: 29304845
[TBL] [Abstract][Full Text] [Related]
22. Changes in capacity to consent over time in patients involved in psychiatric research.
Palmer BW; Savla GN; Roesch SC; Jeste DV
Br J Psychiatry; 2013 Jun; 202(6):454-8. PubMed ID: 23661766
[TBL] [Abstract][Full Text] [Related]
23. Validation of Chinese version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) in patients with schizophrenia spectrum disorders.
Lan TH; Wu BJ; Chen HK; Liao HY; Lee SM; Sun HJ
Psychiatry Res; 2013 Dec; 210(2):634-40. PubMed ID: 23928212
[TBL] [Abstract][Full Text] [Related]
24. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.
Rubright J; Sankar P; Casarett DJ; Gur R; Xie SX; Karlawish J
Am J Geriatr Psychiatry; 2010 Dec; 18(12):1124-32. PubMed ID: 20808101
[TBL] [Abstract][Full Text] [Related]
25. Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia.
Palmer BW; Jeste DV
Schizophr Bull; 2006 Jan; 32(1):98-106. PubMed ID: 16192412
[TBL] [Abstract][Full Text] [Related]
26. Competence of depressed patients for consent to research.
Appelbaum PS; Grisso T; Frank E; O'Donnell S; Kupfer DJ
Am J Psychiatry; 1999 Sep; 156(9):1380-4. PubMed ID: 10484948
[TBL] [Abstract][Full Text] [Related]
27. Participants with schizophrenia retain the information necessary for informed consent during clinical trials.
Fischer BA; McMahon RP; Meyer WA; Slack DJ; Appelbaum PS; Carpenter WT
J Clin Psychiatry; 2013 Jun; 74(6):622-7. PubMed ID: 23842013
[TBL] [Abstract][Full Text] [Related]
28. Decisional capacity for informed consent in schizophrenia research.
Carpenter WT; Gold JM; Lahti AC; Queern CA; Conley RR; Bartko JJ; Kovnick J; Appelbaum PS
Arch Gen Psychiatry; 2000 Jun; 57(6):533-8. PubMed ID: 10839330
[TBL] [Abstract][Full Text] [Related]
29. Correlation Between Insight and Capacity to Consent to Research in Subjects With Bipolar Disorder Type I and Schizophrenia.
López-Jaramillo C; Tobler CA; Gómez CO; Triana JE
Rev Colomb Psiquiatr; 2016; 45(3):194-200. PubMed ID: 27569014
[TBL] [Abstract][Full Text] [Related]
30. Capacity to Consent in Healthcare: A Systematic Review and Meta-Analysis Comparing Patients with Bipolar Disorders and Schizophrenia Spectrum Disorders.
Morena D; Lippi M; Di Fazio N; Delogu G; Rinaldi R; Frati P; Fineschi V
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792947
[No Abstract] [Full Text] [Related]
31. Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects.
Palmer BW; Dunn LB; Depp CA; Eyler LT; Jeste DV
J Clin Psychiatry; 2007 May; 68(5):689-96. PubMed ID: 17503977
[TBL] [Abstract][Full Text] [Related]
32. Spanish Validation of the MacArthur Competence Assessment Tool for Clinical Research Interview for Assessing Patients' Mental Capacity to Consent to Clinical Research.
Baón-Pérez BS; Álvarez-Marrodán I; Navío-Acosta M; Verdura-Vizcaíno EJ; Ventura-Faci T
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):343-351. PubMed ID: 28814135
[TBL] [Abstract][Full Text] [Related]
33. Decisional Capacity to Consent to Clinical Research Involving Placebo in Psychiatric Patients.
Parmigiani G; Mandarelli G; Dacquino C; Pompili P; Lelli Chiesa G; Ferracuti S
J Forensic Sci; 2016 Mar; 61(2):388-393. PubMed ID: 27404612
[TBL] [Abstract][Full Text] [Related]
34. Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.
Mandarelli G; Carabellese F; Parmigiani G; Bernardini F; Pauselli L; Quartesan R; Catanesi R; Ferracuti S
Epidemiol Psychiatr Sci; 2018 Oct; 27(5):492-499. PubMed ID: 28274298
[TBL] [Abstract][Full Text] [Related]
35. The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis.
Wang SB; Wang YY; Ungvari GS; Ng CH; Wu RR; Wang J; Xiang YT
Schizophr Res; 2017 May; 183():56-63. PubMed ID: 27876273
[TBL] [Abstract][Full Text] [Related]
36. Treatment decision-making capacity in hospitalized patients with schizophrenia.
Bilanakis N; Peritogiannis VK; Vratsista A
Psychiatriki; 2017; 28(1):37-45. PubMed ID: 28541237
[TBL] [Abstract][Full Text] [Related]
37. The neuropsychological basis of competence to consent in first-episode schizophrenia: a pilot metacognitive study.
Koren D; Poyurovsky M; Seidman LJ; Goldsmith M; Wenger S; Klein EM
Biol Psychiatry; 2005 Mar; 57(6):609-16. PubMed ID: 15780847
[TBL] [Abstract][Full Text] [Related]
38. Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia.
Raffard S; Bayard S; Eisenblaetter M; Tattard P; Attal J; Laraki Y; Capdevielle D
Eur Arch Psychiatry Clin Neurosci; 2023 Mar; 273(2):511-515. PubMed ID: 35501605
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Capacity to Consent to Research Among Psychiatric Outpatients: Prevalence and Associated Factors.
Morán-Sánchez I; Luna A; Pérez-Cárceles MD
Psychiatr Q; 2016 Mar; 87(1):89-105. PubMed ID: 25952945
[TBL] [Abstract][Full Text] [Related]
40. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
